Thyroid Eye Disease
📧 Sign up to get email alerts when something new happens for Thyroid Eye Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2023-09-28Clinical Trial Update: The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED) [Phase 2, Phase 3]
A study evaluating an antioxidant combination (ASTED) for Thyroid Eye Disease was withdrawn during Phase 2/Phase 3.
-
CLINICAL_TRIALS withdrawal · 2022-01-10Clinical Trial Update: The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease [Phase 2, Phase 3]
A Phase 2/3 trial evaluating an antioxidant combination (ASTED) for moderate to severe Thyroid Eye Disease was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-15Clinical Trial Update: The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients. [Phase 4]
Phase 4 trial investigating secondary benefits of a prostaglandin analog in Thyroid Eye Disease was withdrawn; the study also referenced ocu…